7,246 participants, various community settings
4,701 (65%) tests read
  809 (17%) reactors
  409 eligible for treatment
   84 completed treatment
Bock NN, Metzger BS, Tapia JR, Blumberg HM. American Journal of
Respiratory & Critical Care Medicine. 1999;159:295-300.